Avanlee Care’s $3.5M seed tests whether Medicare Advantage plans will pay to reach caregivers

Medicare Advantage plans can usually see that a member is overdue for a wellness visit or a refill; what they often can't see is the family member who will actually book the appointment. Avanlee Care has raised $3.5 million in seed funding to help those plans identify their members' caregivers.

BEA Venture Fund led the seed round. Existing backers joined it, including board chair Esther Dyson, Chrysalis Ventures and FairBridge VC, MedCity News reported. Avanlee Care has now raised $6 million since its first round in 2021. With the financing, Avanlee Care will expand its technology and enterprise infrastructure and grow its relationships with national health plans and healthcare organizations.

It's a small round with a pointed thesis. The question for a plan's quality or member engagement lead is whether family caregivers can work as a channel for closing care gaps, and whether that channel is worth a line item.

Finding the person behind the overdue visit

The product works in two steps. First, Avanlee Care works with a plan to identify the caregivers of its members. Then it gives those caregivers a shared workspace for scheduling appointments, managing medications, getting vaccination reminders and finding providers. It also offers wellness tools aimed at the strain caregiving puts on the caregiver.

The commerce layer goes further than most care-coordination apps. In her funding announcement, CEO Avanlee Christine wrote that the platform has connected to Walmart's commerce APIs and Mark Cuban Cost Plus Drug Company since 2023, so caregivers can order groceries, health products and lower-cost prescriptions without leaving the app. The company is also using AI to summarize caregiver notes, recommend providers and match caregivers' questions to resources.

According to The SaaS News, the platform also provides health plans with data insights regarding caregiver burnout and member health trends. For a plan, that could mean signals from the home between visits, which Christine describes as visibility into what happens outside clinical settings.

In practice, this connects a plan's gap list to a person at home. A plan already knows a member hasn't filled a prescription. If it can reach the person who drives that member to the pharmacy, the outreach goes to someone who can act on it. Christine says the work runs both ways: connecting caregivers to the health system, and showing plans how caregivers help members follow through on treatment plans.

Where supplemental benefit money is moving

The timing has a data point behind it. In its deal summary, Dealroom cited KFF figures showing caregiver support offered by 5% of Special Needs Plans in 2025 and 16% in 2026. Over the same period, supplemental offerings such as meals and transportation declined. By simple arithmetic, the share of plans offering caregiver support more than tripled in a year.

That doesn't prove plans will buy Avanlee Care in particular. It does suggest that, in at least one segment of Medicare Advantage, caregiver support is gaining ground while other benefits get trimmed. For benefit designers comparing caregiver programs with meal or ride benefits, 16% of Special Needs Plans is a useful reference point.

The caregiver figures come from AARP and the National Alliance for Caregiving, along with a 2025 study in Health Affairs Scholar that Christine cites. MedCity News used the rounder figure of more than 60 million. Either way, the pool is very large. For a plan, the harder problem is finding the specific caregiver tied to a specific member, and that is the piece Avanlee Care is selling.

From family app to plan vendor

Avanlee Care didn't start out selling to insurers. Christine writes that the company began as a consumer app for families and was rebuilt over several years into a platform that works directly with health plans. The caregiver still gets the app free through a participating plan, and the plan pays. She traces the idea to watching her family manage her grandfather's Lewy body dementia and Parkinson's when she was 10, and to an early sales job at Forcura, where she saw how rarely family caregivers were part of care coordination.

Avanlee charges a per-member-per-month fee, according to Dealroom, so payer adoption is make-or-break. Dealroom said the round sits in the 35th percentile for seed deal size, and it noted that the reported expansion and a prospective plan pilot are not yet proof of broad demand or measurable impact.

That is the strongest objection to the thesis, and it's a fair one. A caregiver channel is only worth a monthly fee if the members it reaches complete more visits and fill more prescriptions than they otherwise would. No published plan results answer that yet. For plans whose gap lists are dominated by members with complex chronic conditions, where a family member often handles appointments, the case is easiest to test. For plans whose members mostly manage their own care, the payoff is less clear.

What to ask before signing

For a plan considering a caregiver program, from Avanlee Care or anyone else, three questions turn the pitch into something a quality team can measure. These are editorial suggestions based on how the product is described, not requirements from any regulator.

1. How are caregivers identified and enrolled for a given member, and what share of targeted members end up with an active caregiver on the platform?
2. Which gap-closure measures will the pilot track, such as wellness visit completion, vaccinations and prescription fills, and against what comparison group?
3. How are AI outputs such as provider recommendations and note summaries reviewed before a caregiver acts on them?

The first question matters most for pricing. A per-member fee is spread across every enrolled member, but the benefit only shows up where a caregiver is actually engaged. The share of members reached is what determines the effective cost per engaged member.

For plans weighing the model, the open question is whether caregivers become a lasting part of their quality strategy, which is the bet behind this round. Evidence from plan contracts or pilot results could help answer it.